v1
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.
Identifier:nobleid.org/w1/20260515/ACE605D3
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/ACE605D3)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims